- Home
- SUPN vs RES Comparison
SUPN vs RES Comparison
Compare SUPN & RES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- RES
- Stock Information
- Founded
- SUPN 2005
- RES 1984
- Country
- SUPN United States
- RES United States
- Employees
- SUPN N/A
- RES N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- RES Oilfield Services/Equipment
- Sector
- SUPN Health Care
- RES Energy
- Exchange
- SUPN Nasdaq
- RES Nasdaq
- Market Cap
- SUPN 1.9B
- RES 1.5B
- IPO Year
- SUPN 2012
- RES N/A
- Fundamental
- Price
- SUPN $35.57
- RES $5.73
- Analyst Decision
- SUPN Hold
- RES Sell
- Analyst Count
- SUPN 1
- RES 3
- Target Price
- SUPN $36.00
- RES $6.08
- AVG Volume (30 Days)
- SUPN 422.4K
- RES 1.6M
- Earning Date
- SUPN 11-04-2024
- RES 10-24-2024
- Dividend Yield
- SUPN N/A
- RES 2.79%
- EPS Growth
- SUPN 130.79
- RES N/A
- EPS
- SUPN 1.07
- RES 0.55
- Revenue
- SUPN $651,972,000.00
- RES $1,474,169,000.00
- Revenue This Year
- SUPN $7.82
- RES N/A
- Revenue Next Year
- SUPN N/A
- RES N/A
- P/E Ratio
- SUPN $33.25
- RES $10.36
- Revenue Growth
- SUPN 6.79
- RES N/A
- 52 Week Low
- SUPN $25.53
- RES $5.63
- 52 Week High
- SUPN $39.37
- RES $8.19
- Technical
- Relative Strength Index (RSI)
- SUPN 53.46
- RES 40.03
- Support Level
- SUPN $35.87
- RES $5.93
- Resistance Level
- SUPN $39.37
- RES $6.27
- Average True Range (ATR)
- SUPN 1.69
- RES 0.22
- MACD
- SUPN 0.03
- RES 0.00
- Stochastic Oscillator
- SUPN 36.03
- RES 11.49
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About RES RPC Inc.
RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment consists of pressure pumping, downhole tools, coiled tubing, snubbing, nitrogen, well control, wireline, and fishing. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.